Emerging studies from other groups as well as our own have revealed a critical oncogenic role of BAP1 in multiple human cancers, including breast cancer [19], leukemia [16, 29, 31], and small cell lung cancer (SCLC) [15, 32]. This evidence concerns the gene BAP1 and breast carcinoma.